| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 137061-48-4 | 腺苷酸環(huán)化酶激活肽-38(抗原) | H-HIS-SER-Asp-Gly-ILE-PHE-THR-Asp-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-AL; H-HIS-SER-Asp-Gly-ILE-PHE-THR-Asp-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-Gly-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; HIS-SER-Asp-Gly-ILE-PHE-THR-Asp-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-Gly-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 無 | C203H331N63O53S1 | 詳情 | 供應商 |
| 107015-83-8 | 淀粉-Β-蛋白片段12-28 | H-VAL-HIS-HIS-Gln-LYS-Leu-VAL-PHE-PHE-ALA-GLU-Asp-VAL-Gly-SER-ASN-LYS-OH; H-VAL-HIS-HIS-Gln-LYS-Leu-VAL-PHE-PHE-ALA-GLU-Asp-VAL-Gly-SER-ASN-LYS-OH; BETA-AMYLOID (12-28); BETA-AMYLOID PEPTIDE [12-28], HUMAN; ALZHEIMER'S DISEASE BETA-PROTEIN (12-28); AMYLOID, BETA- (12-28), HUMAN; AMYLOID BETA-PROTEIN (12-28); AMYLOID-BETA PROTEIN (12-28), HUMAN; AMYLOID BETA-PROTEIN FRAGMENT 12-28 |  | C89H135N25O25 | 詳情 | 供應商 |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-Asp-ALA-GLU-PHE-ARG-HIS-Asp-SER-Gly-TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-PHE-PHE-ALA-GLU-Asp-VAL-GL; PREDOMINANT AMYLOID B-PROTEIN FRAGMENT; Asp-ALA-GLU-PHE-ARG-HIS-Asp-SER-Gly-TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-PHE-PHE-ALA-GLU-Asp-VAL-Gly-SER-ASN-LYS-Gly-ALA-ILE-ILE-Gly-Leu-MET-VAL-Gly-Gly-VAL-VAL-ILE-ALA; Asp-ALA-GLU-PHE-Gly-HIS-Asp-SER-Gly-PHE-GLU-VAL-ARG-HIS-Gln-LYS-Leu-VAL-PHE-PHE-ALA-GLU-Asp-VAL-Gly-SER-ASN-LYS-Gly-ALA-ILE-ILE-Gly-Leu-MET-VAL-Gly-Gly-VAL-VAL-ILE-ALA; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 無 | C203H311N55O60S | 詳情 | 供應商 |
| 90984-99-9 | ARG-ARG-SER-SER-CYS-PHE-Gly-Gly-ARG-ILE-Asp-ARG-ILE-Gly-ALA-Gln-SER-Gly-Leu-Gly-CYS-ASN-SER-PHE-ARG- | ARG-ARG-SER-SER-CYS-PHE-Gly-Gly-ARG-ILE-Asp-ARG-ILE-Gly-ALA-Gln-SER-Gly-Leu-Gly-CYS-ASN-SER-PHE-ARG-; H-ARG-ARG-SER-SER-CYS-PHE-Gly-Gly-ARG-ILE-Asp-ARG-ILE-Gly-ALA-Gln-SER-Gly-Leu-Gly-CYS-ASN-SER-PHE-ARG-TYR-OH; ATRIAL NATRIURETIC PEPTIDE RAT FRAGMENT 3-28; ATRIAL NATRIURETIC FACTOR (3-28) (RAT); ATRIAL NATRIURETIC PEPTIDE (3-28), RAT; A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 3-28); ARG-ARG-SER-SER-CYS-PHE-Gly-Gly-ARG-ILE-Asp-ARG-ILE-Gly-ALA-Gln-SER-Gly-Leu-Gly-CYS-ASN-SER-PHE-ARG-TYR; ANP (RAT, 3-28); ANP (3-28), RAT |  | C119H189N43O36S2 | 詳情 | 供應商 |
| 98474-59-0 | 豚鼠髓磷脂堿性蛋白片段68-82 | TYR-Gly-SER-Leu-PRO-Gln-LYS-SER-Gln-ARG-SER-Gln-Asp-GLU-ASN; H-TYR-Gly-SER-Leu-PRO-Gln-LYS-ALA-Gln-ARG-PRO-Gln-Asp-GLU-ASN-OH; H-TYR-Gly-SER-Leu-PRO-Gln-LYS-SER-Gln-ARG-SER-Gln-Asp-GLU-ASN-OH; (DES-Gly77,DES-HIS78)-MYELIN BASIC PROTEIN (68-84) (BOVINE); (DES-Gly77,DES-HIS78)-MYELIN BASIC PROTEIN (68-84) (GUINEA PIG); DES-Gly77, DES-HIS78-MYELIN BASIC PROTEIN FRAGMENT 68-84 BOVINE; DES-[Gly77,HIS78] MYELIN BASIC PROTEIN (68-84), BOVINE; DES[Gly77,HIS78]-MYELIN BASIC PROTEIN, FRAGMENT 68-64; DES[Gly77, HIS78]-SER75,80-MYELIN BASIC PROTEIN BOVINE FRAGMENT 68-84 |  | C71H113N23O28 | 詳情 | 供應商 |
| 56795-64-3 | THYMOPOIETIN I/II (29-41) (BOVINE) | Gly-GLU-Gln-ARG-LYS-Asp-VAL-TYR-VAL-Gln-Leu-TYR-Leu; THYMOPOIETIN I/II (29-41) (BOVINE); THYMOPOIETIN II FRAGMENT 29-41; THYMOPOIETIN II (29-41); TP II FRAGMENT (29-41); (Asp34)-THYMOPOIETIN III (29-41) (BOVINE); (GLU38)-THYMOPOIETIN (29-41) (HUMAN, MOUSE); Gly-GLU-Gln-ARG-LYS-Asp-VAL-TYR-VAL-Gln-Leu-TYR-Leu; Gly-GLU-Gln-ARG-LYS-Asp-VAL-TYR-VAL-GLU-Leu-TYR-Leu |  | C73H115N19O22 | 詳情 | 供應商 |
| 205640-90-0 | OREXIN A (HUMAN, BOVINE, CANINE, MOUSE, OVINE, PORCINE, RAT) | PYR-PRO-Leu-PRO-Asp-CYS-CYS-ARG-Gln-LYS-THR-CYS-SER-CYS-ARG-Leu-TYR-GLU-Leu-Leu-HIS-Gly-ALA-Gly-ASN-; HYPOCRETIN; PYR-PRO-Leu-PRO-Asp-CYS-CYS-ARG-Gln-LYS-THR-CYS-SER-CYS-ARG-Leu-TYR-GLU-Leu-Leu-HIS-Gly-ALA-Gly-ASN-HIS-ALA-ALA-Gly-ILE-Leu-THR-Leu-NH2; PYR-PRO-Leu-PRO-Asp-CYS-CYS-ARG-Gln-LYS-THR-CYS-SER-CYS-ARG-Leu-TYR-GLU-Leu-Leu-HIS-Gly-ALA-Gly-ASN-HIS-ALA-ALA-Gly-ILE-Leu-THR-Leu-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); PYR-PLPDCCRQKTCSCRLYELLHAGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); OREXINS OREXIN A HUMAN, RAT, MOUSE; OREXIN A, BOVINE, HUMAN, MOUSE, RAT |  | C152H247N47O44S4 | 詳情 | 供應商 |
| 143748-18-9 | PACAP (6-38), HUMAN, OVINE, RAT | H-PHE-THR-Asp-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-Gly-LYS-AR; FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; HIS-SER-Asp-Gly-ILE-PHE-THR-AP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-Gly-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; H-PHE-THR-Asp-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-Gly-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; PHE-THR-Asp-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-Gly-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT) |  | C203H331N63O65S | 詳情 | 供應商 |
| 122613-29-0 | Leu-Leu-TYR-GLU-MET-Leu-ALA-Gly-Gln-ALA-PRO-PHE-GLU-Gly-GLU-Asp-GLU-Asp-GLU-Leu-PHE-Gln-SER-ILE-MET- | H-Leu-Leu-TYR-GLU-MET-Leu-ALA-Gly-Gln-ALA-PRO-PHE-GLU-Gly-GLU-Asp-GLU-Asp-GLU-Leu-PHE-Gln-SER-ILE-ME; PKC (530-558); PKC FRAGMENT (530-558); PROTEIN KINASE C (530-558); PROTEIN KINASE C FRAGMENT 530-558; LLYEMLAGQAPFEGEDEDELFQSIMEHNV; LLYEMLAGQAPFEGEDEDELFQSIMEHNV-NH2; H-Leu-Leu-TYR-GLU-MET-Leu-ALA-Gly-Gln-ALA-PRO-PHE-GLU-Gly-GLU-Asp-GLU-Asp-GLU-Leu-PHE-Gln-SER-ILE-MET-GLU-HIS-ASN-VAL-NH2; H-Leu-Leu-TYR-GLU-MET-Leu-ALA-Gly-Gln-ALA-PRO-PHE-GLU-Gly-GLU-Asp-GLU-Asp-GLU-Leu-PHE-Gln-SER-ILE-MET-GLU-HIS-ASN-VAL-NH2 |  | C148H221N35O50S2 | 詳情 | 供應商 |
| 112955-31-4 | ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS- | ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-; PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE); PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE); ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2; HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM; ala-val-ser-glu-his-Gln-Leu-Leu-his-Asp-lys-Gly-lys-ser-ile-Gln-Asp-Leu-arg-arg-arg-phe-phe-Leu-his-his-Leu-ile-ala-glu-ile-his-thr-ala-nh2; Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2; Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 無 | C180H288N58O47 | 詳情 | 供應商 |
| 89105-94-2 | FIBRINOGEN-BINDING INHIBITOR PEPTIDE | HIS-HIS-Leu-Gly-Gly-ALA-LYS-Gln-ALA-Gly-Asp-VAL; FIBRINOGEN Y-CHAIN DODECAPETIDE; FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE; FIBRINOGEN-BINDING INHIBITOR PEPTIDE; HUMAN FIBRINOGEN-GAMMA FRAGMENT 400-411; HHLGGAKQAGDV; H-HIS-HIS-Leu-Gly-Gly-ALA-LYS-Gln-ALA-Gly-Asp-VAL-OH; HIS-HIS-Leu-Gly-Gly-ALA-LYS-Gln-ALA-Gly-Asp-VAL; fibrinogen-γ fragment 400-411 |  | C50H80N18O16 | 詳情 | 供應商 |
| 136461-80-8 | TYR-Leu-TYR-Gln-TRP-Leu-Gly-ALA-PRO-VAL-PRO-TYR-PRO-Asp-PRO-Leu-GLA-PRO-ARG-ARG-GLA-VAL-CYS-GLA-Leu- | H-TYR-Leu-TYR-Gln-TRP-Leu-Gly-ALA-PRO-VAL-PRO-TYR-PRO-Asp-PRO-Leu-GLA-PRO-ARG-ARG-GLA-VAL-CYS-GLA-LE; OSTEOCALCIN (HUMAN, GLA17,21,24); OSTEOCALCIN (1-49) (HUMAN); TYR-Leu-TYR-Gln-TRP-Leu-Gly-ALA-PRO-VAL-PRO-TYR-PRO-Asp-PRO-Leu-GLA-PRO-ARG-ARG-GLA-VAL-CYS-GLA-Leu-ASN-PRO-Asp-CYS-Asp-GLU-Leu-ALA-Asp-HIS-ILE-Gly-PHE-Gln-GLU-ALA-TYR-ARG-ARG-PHE-TYR-Gly-PRO-VAL; YLYQWLGAPVPYPDPL-GLA-PRR-GLA-VC-GLA-LNPDCDELADHIGFQEAYRRFYGPV; H-TYR-Leu-TYR-Gln-TRP-Leu-Gly-ALA-PRO-VAL-PRO-TYR-PRO-Asp-PRO-Leu-GLA-PRO-ARG-ARG-GLA-VAL-CYS-GLA-Leu-ASN-PRO-Asp-CYS-Asp-GLU-Leu-ALA-Asp-HIS-ILE-Gly-PHE-Gln-GLU-ALA-TYR-ARG-ARG-PHE-TYR-Gly-PRO-VAL-OH; [GLA17,21,24]-OSTEOCALCIN (1-49); GLA17,21,24-OSTEOCALCIN (HUMAN); BONE GLA PROTEIN (HUMAN) | 無 | 詳情 | 供應商 | |
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-Gln-Leu-Leu-HIS-Asp-LYS-Gly-LYS-SER-ILE-Gln-Asp-Leu-ARG-ARG-ARG-PHE-PHE-Leu-HIS-HIS-Leu-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 無 | C180H287N57O48 | 詳情 | 供應商 |